Le Lézard
Classified in: Business
Subject: v

Becker Milk Company Announces Special Dividend


TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The Becker Milk Company Limited (the "Company") (TSX-BEK.B) announces the declaration of a special dividend.

SPECIAL DIVIDEND

The Directors of the Company have declared a special dividend on Class B Special and Common Shares of $1.00 per share. This dividend will be paid to those shareholders of record as of January 24, 2024 and payable on January 31, 2024.

The dividend will be considered as an eligible dividend for Canadian tax purposes.

For the Board of Directors
G.W.J. Pottow, President
Tel: 416-698-2591



These press releases may also interest you

at 19:05
S&P MidCap 400 constituent Vistra Corp. will replace Pioneer Natural Resources Co. in the S&P 500, S&P SmallCap 600 constituent Aaon Inc. (NASD: AAON) will replace Vistra in the S&P MidCap 400, and Marathon Digital Holdings Inc. (NASD: MARA) will...

at 19:00
Vizsla Silver Corp. ("Vizsla Silver" or the "Company") is pleased to announce that it has now issued 448,137 common shares (the "Consideration Shares") for the previously announced asset purchase agreement (the "Acquisition Agreement") dated March...

at 18:56
Frontenac Mortgage Investment Corporation ("FMIC") announces that it has filed amended and restated interim unaudited financial statements and related management's discussion and analysis ("MD&A") for the quarters ended March 31, 2023, June 30, 2023...

at 18:16
Capital Community Bank (CCBank), a leader in Utah community banking, is excited to announce the successful acquisition of Security Home Mortgage (SHM), a well-respected provider of home mortgage solutions since 1999. This landmark deal marks a...

at 18:05
Stellus Capital Investment Corporation will release its financial results for the first quarter ended March 31, 2024 on Thursday, May 9, 2024, after the close of the stock market....

at 18:00
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...



News published on and distributed by: